The role of chemotherapy in biliary tract carcinoma

Por Verslype, C., Prenen, H., Van Cutsem, E.
Publicado em 2008

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

Por Macarulla, T, Cervantes, A, Tabernero, J, Roselló, S, Van Cutsem, E, Tejpar, S, Prenen, H, Martinelli, E, Troiani, T, Laffranchi, B, Jego, V, von Richter, O, Ciardiello, F
Publicado no Br J Cancer (2015)

Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis

Por De Smedt, L, Lemahieu, J, Palmans, S, Govaere, O, Tousseyn, T, Van Cutsem, E, Prenen, H, Tejpar, S, Spaepen, M, Matthijs, G, Decaestecker, C, Moles Lopez, X, Demetter, P, Salmon, I, Sagaert, X
Publicado no Br J Cancer (2015)

PD-030 Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal...

Por Van Cutsem, E., Decoster, L., Houbiers, G., Naessens, B., De Man, M., Lambrecht, G., Monsaert, E., Moons, V., Vergauwe, P., Kenis, C., Wildiers, H., Opstaele, L., Van De Walle, E., Prenen, H.
Publicado no Ann Oncol (2016)